Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (Weighted Average) (2016 - 2025)

Creative Medical Technology Holdings has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $6.1 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 91.56% to $6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, up 91.56% year-over-year, with the annual reading at $6.1 million for FY2025, 91.56% up from the prior year.
  • Shares Outstanding (Weighted Average) was $6.1 million for Q4 2025 at Creative Medical Technology Holdings, up from $2.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $1.1 billion in Q2 2021 and troughed at $773970.0 in Q2 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $2.3 million (2022), against an average of $58.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 1039.82% in 2021 and later tumbled 99.93% in 2022.
  • Tracing CELZ's Shares Outstanding (Weighted Average) over 5 years: stood at $6.6 million in 2021, then plummeted by 83.45% to $1.1 million in 2022, then soared by 109.01% to $2.3 million in 2023, then surged by 39.38% to $3.2 million in 2024, then soared by 91.56% to $6.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $6.1 million, $2.6 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.